Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects
Huawei Tong, Jia Huang, Qingquan Xiao, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 108-119
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase
Huawei Tong, Xuchen Wang, Yuanhua Liu, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 8, pp. 1080-1084
Closed Access | Times Cited: 116
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
Jianli Tao, Daniel E. Bauer, Roberto Chiarle
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 95
CRISPR‐Cas Biochemistry and CRISPR‐Based Molecular Diagnostics
Zhengyan Weng, Zheng You, Jie Yang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 17
Open Access | Times Cited: 79
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing
Xiangfeng Kong, Hainan Zhang, Guoling Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
CRISPR technologies for genome, epigenome and transcriptome editing
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 54
The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model
Yunfei Li, Junjie Xu, Xuefei Guo, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 46
Precise transcript targeting by CRISPR-Csm complexes
David Colognori, Marena Trinidad, Jennifer A. Doudna
Nature Biotechnology (2023) Vol. 41, Iss. 9, pp. 1256-1264
Open Access | Times Cited: 44
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox
Eugene V. Koonin, Jonathan S. Gootenberg, Omar O. Abudayyeh
Biochemistry (2023) Vol. 62, Iss. 24, pp. 3465-3487
Open Access | Times Cited: 43
Collateral activity of the CRISPR/RfxCas13d system in human cells
Peiguo Shi, Michael R. Murphy, Alexis O. Aparicio, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 41
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
Victor Tieu, Elena Sotillo, Jeremy Bjelajac, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1278-1295.e20
Closed Access | Times Cited: 34
Structures, mechanisms and applications of RNA-centric CRISPR–Cas13
Hui Yang, Dinshaw J. Patel
Nature Chemical Biology (2024) Vol. 20, Iss. 6, pp. 673-688
Closed Access | Times Cited: 13
Tracking endogenous proteins based on RNA editing-mediated genetic code expansion
Min Hao, Xinyu Ling, Yi Sun, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 6, pp. 721-731
Closed Access | Times Cited: 12
A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD
Tristan X. McCallister, Colin K.W. Lim, Madhurima Singh, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Efficient combinatorial targeting of RNA transcripts in single cells with Cas13 RNA Perturb-seq
Hans‐Hermann Wessels, Alejandro Méndez‐Mancilla, Yuhan Hao, et al.
Nature Methods (2022) Vol. 20, Iss. 1, pp. 86-94
Open Access | Times Cited: 42
Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase
Huawei Tong, Nana Liu, Yinghui Wei, et al.
National Science Review (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 30
Subcellular visualization: Organelle-specific targeted drug delivery and discovery
Xintian Shao, Caicai Meng, Wenjing Song, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114977-114977
Closed Access | Times Cited: 30
CasTuner is a degron and CRISPR/Cas-based toolkit for analog tuning of endogenous gene expression
Gemma Noviello, Rutger A. F. Gjaltema, Edda G. Schulz
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model
Zhifang Li, Ruochen Guo, Xiao-Zhi Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells
Chloe Ding, Cristina Tous, Jaehoon Choi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase
Huawei Tong, Haoqiang Wang, Xuchen Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair
Lu Wang, Mainá Bitar, Xue Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Antonios Apostolopoulos, Naohiro Kawamoto, Siu Yu A. Chow, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Low copy CRISPR-Cas13d mitigates collateral RNA cleavage
Sydney K. Hart, Hans‐Hermann Wessels, Alejandro Méndez‐Mancilla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Sustained efficacy of CRISPR-Cas13b gene therapy for FSHD is challenged by immune response to Cas13b
Afrooz Rashnonejad, Manal Farea, Gholamhossein Amini Chermahini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
CRISPR/Cas13X-assisted programmable and multiplexed translation regulation for controlled biosynthesis
X. Xu, Xueqin Lv, Yanfeng Liu, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top